MOH — authorised 28 March 2017
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: likely_approved
🇮🇱 Dupixent in Israel
MOH authorised Dupixent on 28 March 2017
Marketing authorisation
Dupixent in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Israel
Frequently asked questions
Is Dupixent approved in Israel?
Yes. MOH authorised it on 28 March 2017.
Who is the marketing authorisation holder for Dupixent in Israel?
REGENERON PHARMACEUTICALS holds the Israeli marketing authorisation.